Immuno-hematologic consequences of obesity: focus on leukocytosis and myeloid dysfunction

نویسندگان
doi
10.48309/jmpcr.2026.572267.1988
چکیده

Obesity is accompanied by chronic, low-grade inflammation and reproducible alterations in hematologic parameters, most notably relative and sometimes absolute leukocytosis. Obesity-associated leukocytosis reflects increased production, marrow egress, and peripheral redistribution of multiple leukocyte lineages, particularly neutrophils and monocytes. These changes are driven by inflamed adipose tissue, adipokines such as leptin, systemic cytokines including IL-1β, IL-6, and G-CSF, and disrupted hematopoietic niche signaling. Leukocyte expansion and activation contribute to cardiometabolic disease, impaired host defense, prothrombotic phenotypes, endothelial dysfunction, and altered cancer immunobiology. Clinical and experimental data demonstrate that intentional weight loss and metabolic or bariatric surgery consistently reduce circulating leukocyte counts and inflammatory biomarkers, indicating partial reversibility of obesity-related hematologic remodeling. This review integrates epidemiologic evidence with cellular and molecular mechanisms, delineates lineage-specific quantitative and functional changes, discusses clinical implications across cardiovascular, metabolic, and oncologic contexts, and evaluates emerging therapeutic and lifestyle interventions. The unresolved questions and priorities for future translational and mechanistic research are also highlighted.